When you think of clinical trials for cancer, testing a new medication may come to mind. But drugs aren’t the only thing these trials investigate. There’s a growing world of nonpharmaceutical clinical ...

Sarah Anderson, oncology strategy lead director, Novotech, discusses the growing prominence of triple-negative breast cancer clinical trials in the Asia-Pacific region, and the significant investments ...

An expert shares information on a pair of noteworthy active trials in breast cancer that patients should be aware of. For patients with triple-negative breast cancer, there are now several clinical ...

Editor’s note: This round‑up is based on press releases, peer‑reviewed publications, and company communications received in January and February 2026. All results are preliminary unless stated, and ...

Despite the many benefits of clinical trials, misconceptions still exist. Get the facts, so you can make an informed choice about whether applying for a trial is right for you. Whether you are at the ...

Awareness Month, which raises awareness, action, and amplifies the voices of individuals impacted by MM, a blood cancer in which abnormal plasma cells build up in the bone marrow, producing large ...

Many people think of clinical trials as a last-ditch effort for cancer patients. In 2025, amid a flurry of new treatments enabling people diagnosed with cancer to live longer and better, ...

Clinical trials are vital for developing safer, more effective metastatic breast cancer treatments, yet participation is low due to access and financial barriers. Trials progress through phases, from ...

A leading oncologist proposes classifying metastatic cancer by molecular alterations rather than organ origin, arguing that the shift could accelerate drug access.

When Jon and Dayla Culp received the news that their six-year-old Labrador retriever, Clarice, had a malignant tumor near her left wrist, the couple was devastated. Dayla had lost her sister, Darcy ...